Purchase Order 75N93023P00704

Award Date 5/31/23
Potential Completion Date 9/30/23
Potential Value $79K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Franklin Lakes, NJ 07417, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $7,265 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to Becton, Dickinson and Company (BD) for an upgrade to the FACSCALIBUR acquisition bundle. The original solicitation appears to have been for laboratory equipment and supplies to support biomedical research and clinical applications. BD is a global medical technology company that has received numerous federal contract and...
This is a $379,912 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Becton, Dickinson and Company (BD) for an LSRFORTESSA X20 flow cytometer. The contract has no set-aside designation and was awarded on July 19, 2016, with a completion date of August 26, 2016. BD is a global medical technology company that provides a wide range of instruments, reagents, and services to...
This is a $407,072.31 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD). The contract is for a service agreement to maintain and repair five BD FACSymphony A5 flow cytometers, one BD FACSymphony S6 cell sorter, four high throughput samplers, and associated lasers used by NIAID's Vaccine Research Center. This equipment supports time-sensitive...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $39,995.00 Firm Fixed Price Purchase Order to Becton, Dickinson and Company (BD) for a FACS CALIBUR HIGH THROUGHPUT SAMPLE UPGRADE. This is not a set-aside contract. BD is a global medical technology company that provides instruments, reagents, and services to support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics technologies. BD has a long history of federal...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded Becton, Dickinson And Company (BD) a $104,434.80 firm fixed price purchase order for annual maintenance on a Facscelesta flow cytometer instrument, including a throughput sampler and sampler. The award date was July 22, 2019 and the completion date is September 28, 2024. No set-aside was used for this competition. BD is a global medical technology company that...
This is a $99,717.48 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, to Becton, Dickinson and Company (BD). The contract is for the provision of three LSR FORTESSA flow cytometers with laser systems, as well as an annual service agreement. There is no set-aside designation for this award. BD is a major manufacturer of medical devices, instruments, and supplies, including...
The National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $76,248.00 firm-fixed-price purchase order to Becton, Dickinson And Company (BD) for a service agreement to maintain a FACSymphony S6 flow cytometer sorter and associated laser equipment. The contract runs from February 1, 2025 to January 31, 2026 and includes two preventive maintenance inspections per year, unlimited service visits, and 48-hour emergency response. This procurement was...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $719,435 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for the delivery of one BD FACSymphony S6 Cell Sorter system. The system will meet requirements specified in the solicitation including the ability to simultaneously detect 50 parameters and sort clustered cell populations. It will be...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Becton, Dickinson and Company (BD) for an annual service agreement covering a FACSymphony A5 flow cytometer with five lasers, a flow supply system, and a high-throughput sampler. The total ceiling value of the contract is $47,853.48. The contract does not have a set-aside designation. This award is part of BD's...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Becton, Dickinson & Co. (BD) for the purchase of a BD FACSymphony S6 cell sorter valued at $764,203.60. The contract has an ultimate completion date of September 29, 2025. The contract does not have a set-aside designation. BD has received numerous federal contract awards as both a prime and subcontractor...

This is a $79,486.17 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, to Becton, Dickinson & Co (BD) for the upgrade of BD's FACSCelesta SORP flow cytometer system. The upgrade includes the addition of a small particle side scatter detector and a high throughput sampler, which will enhance NIAID's Laboratory of Immunoregulation's research capabilities in understanding the pandemic emergence of SARS-CoV-2 and its impact on the immune response. This award was made on an other than full and open competition basis due to BD's proprietary components being required for compatibility with NIAID's existing FACSCelesta SORP system. No set-aside designation was used for this contract.

Generated 4/1/25, 8:43 PM